Paper39300073
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Shan Q and 22 others. Signal Transduct Target Ther, 2024. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Papers, record 39300073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39300073
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Quinolines | Major topic |
| Liver Neoplasms | Major topic |
| Hypoxia-Inducible Factor 1, alpha Subunit | Major topic |
| Phenylurea Compounds | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Ubiquitin Thiolesterase | Major topic |
| Neoplastic Stem Cells | Major topic |
| Humans | |
| Myosin Heavy Chains | |
| Mice | |
| Cell Line, Tumor | |
| Animals | |
| Gene Expression Regulation, Neoplastic | |
| Male |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 92159202 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82203070 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82200727 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82200726 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82273270 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31622608 | Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. | Life Sci | 2019 | https://conductscience.org/library/papers/31622608 | PubMed |
| 2 | 29307467 | Hepatocellular carcinoma. | Lancet | 2018 | https://conductscience.org/library/papers/29307467 | PubMed |
| 3 | 33832339 | Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA. | Future Oncol | 2021 | https://conductscience.org/library/papers/33832339 | PubMed |
| 4 | 39068164 | DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39068164 | PubMed |
| 5 | 37117273 | Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37117273 | PubMed |
| 6 | 38045832 | Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/38045832 | PubMed |
| 7 | 24436421 | Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. | Science | 2014 | https://conductscience.org/library/papers/24436421 | PubMed |
| 8 | 35683032 | Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35683032 | PubMed |
| 9 | 37482600 | Application of multi-modality MRI-based radiomics in the pre-treatment prediction of RPS6K expression in hepatocellular carcinoma. | Mol Biomed | 2023 | https://conductscience.org/library/papers/37482600 | PubMed |
| 10 | 39156893 | Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39156893 | PubMed |
| 11 | 25453096 | Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25453096 | PubMed |
| 12 | 17567956 | Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. | Mol Biol Cell | 2007 | https://conductscience.org/library/papers/17567956 | PubMed |
| 13 | 38634741 | Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer. | Mol Carcinog | 2024 | https://conductscience.org/library/papers/38634741 | PubMed |
| 14 | 38241695 | N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression. | Cancer Res | 2024 | https://conductscience.org/library/papers/38241695 | PubMed |
| 15 | 35767704 | Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma. | Cancer Res | 2022 | https://conductscience.org/library/papers/35767704 | PubMed |
| 16 | 34470658 | The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34470658 | PubMed |
| 17 | 35124127 | Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis. | J Control Release | 2022 | https://conductscience.org/library/papers/35124127 | PubMed |
| 18 | 37935888 | Deubiquitinases in cancer. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/37935888 | PubMed |
| 19 | 39149512 | Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39149512 | PubMed |
| 20 | 39060914 | Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA). | Cell Biochem Biophys | 2024 | https://conductscience.org/library/papers/39060914 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42934489 | Tip60-Mediated USP22 Lactylation Drives Glutamine Metabolic Reprogramming via SLC25A5 in TNBC. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42934489 | PubMed |
| 42928059 | Tumor-derived annexin A1 drives lenvatinib resistance by regulating SOX2/STAT3/S100A6 feedback loop and M2 macrophage polarization in hepatocellular carcinoma. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42928059 | PubMed |
| 42890758 | MYH9 confers doxorubicin resistance by stabilizing GRP78 and suppressing the PERK signaling-driven apoptotic pathway in breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42890758 | PubMed |
| 42859251 | E3 ubiquitin ligase-mediated necroptosis: regulatory mechanisms and therapeutic implication in cancer. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42859251 | PubMed |
| 42850382 | LAIR1 suppresses phagocytosis via SHP2/USP22-mediated MYH9 degradation in glioma-associated microglia/macrophages to drive immunosuppression. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42850382 | PubMed |
| 42794777 | Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794777 | PubMed |
| 42770181 | Exosomal circ-ZNF652 Mediates TGF-β1-Induced Epithelial-Mesenchymal Transition and Glycolytic Reprogramming to Promote Hepatocellular Carcinoma Progression. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42770181 | PubMed |
| 42724826 | Hypoxia-inducible factor-1α promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724826 | PubMed |
| 42687478 | Stemness plasticity in hepatocellular carcinoma: spatial niches and therapeutic implications. | J Liver Cancer | 2026 | https://conductscience.org/library/papers/42687478 | PubMed |
| 42592210 | HIFs: The central drivers of tumors and their role as molecular switches in targeted therapy? | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42592210 | PubMed |
| 42415626 | Remodelling the tumour microenvironment and beyond: ERO1A as a multifaceted regulator and emerging therapeutic target in cancer. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42415626 | PubMed |
| 42404106 | Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42404106 | PubMed |
| 42394399 | Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42394399 | PubMed |
| 42373728 | GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42373728 | PubMed |
| 42360649 | Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. | Med Oncol | 2026 | https://conductscience.org/library/papers/42360649 | PubMed |
| 42263684 | SPACE-seq integrates spatial transcriptomics and lineage tracing in native tissues. | Cell Stem Cell | 2026 | https://conductscience.org/library/papers/42263684 | PubMed |
| 42220612 | Calcium peroxide loaded liposomes reprogram hypoxic and acidic tumor microenvironment to overcome lenvatinib resistance in hepatocellular carcinoma. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42220612 | PubMed |
| 42207429 | Understanding how hypoxia contributes to liver cancer stem cells maintenance. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42207429 | PubMed |
| 42192118 | Activation of methionine metabolism mediated by HNF4α confers ferroptosis resistance in hepatocellular carcinoma. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42192118 | PubMed |
| 42174129 | FLRT2 promotes foam cell formation and atherosclerosis by inhibiting USP22-mediated ABCA1 deubiquitination. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42174129 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| MYH9 | 4627 | PubTator's text mining | https://conductscience.org/library/genes/4627 | NCBI Gene |
| USP22 | 23326 | PubTator's text mining | https://conductscience.org/library/genes/23326 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39300073
GET https://conductscience.org/api/papers/v1/39300073/authors?page=2